Comparison of the Effect of Red Wine With Alcohol on Flow-mediated Dilation Versus Red Wine Without Alcohol

Launched by INSTITUTO DE CARDIOLOGIA DE SANTA CATARINA · Jul 30, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how red wine affects blood vessel health compared to non-alcoholic red wine. The researchers want to see if drinking red wine can improve a specific function of the blood vessels, known as flow-mediated dilation, which is important for cardiovascular health. They will involve 20 healthy participants who drink alcohol occasionally. Each participant will try both types of wine over a two-week period, with a week in between to allow their bodies to reset.

To be eligible for the trial, participants should be between the ages of 65 and 74 and should not be taking continuous medications, including anti-inflammatory drugs, or be pregnant. The trial is currently not recruiting, but once it starts, participants can expect to have their blood vessel function measured before and after drinking each type of wine. The findings could help us understand how different types of wine can impact heart health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • consume alcohol sporadically
• Exclusion Criteria:
• • continuous medication, including anti-inflammatories
• • pregnant women